Nifty

:

25959.50

Sensex

:

84900.71

-108.65 (-0.42%)
-331.21 (-0.39%)

Login

Nifty
Sensex

:
:

25959.50
84900.71

-108.65 (-0.42%)
-331.21 (-0.39%)

Shukra Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

73/99

BSE: 524632 | NSE: Not Listed

Watchlist

NSE BSE

38.85

24-Nov-2025

Open
High
Low
Previous Close

39
41.95
38.85
40.89

Volume
Traded Value (lacs)
52 Week High
52 Week Low

159447
6247138
44.31
5.76

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,790.49
149.72
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,780.89
0.02%
27.21

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

21.04
23.82
-17.87

EBITDA CAGR (%)

10 Years
5 Years
3 Years

26.74
54.42
18.89

PAT CAGR (%)

10 Years
5 Years
3 Years

54.96
119.04
29.51

P:E (Median)

8 Years
5 Years
3 Years

23.35
30.95
32.13

P:BV (Average)

8 Years
5 Years
3 Years

4.75
5.19
7.90

EV:EBITDA (Average)

8 Years
5 Years
3 Years

18.48
22.77
30.61

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 5.88 5.55 5.95% 5.39 3.18 69.50% 13.27 10.88 21.97% 10.58 18.89 -43.99%
Expenses 6.30 4.89 28.83% 4.07 2.37 71.73% 5.95 6.45 -7.75% 6.65 9.35 -28.88%
EBITDA -0.42 0.67 - 1.32 0.80 65.00% 7.32 4.43 65.24% 3.94 9.54 -58.70%
EBIDTM -7.15% 12.01% 24.45% 25.33% 55.16% 40.74% 37.22% 50.52%
Other Income 1.71 1.02 67.65% 1.11 0.72 54.17% 1.47 1.38 6.52% 1.01 0.56 80.36%
Interest 0.29 0.11 163.64% 0.27 0.06 350.00% 0.27 0.07 285.71% 0.15 0.07 114.29%
Depreciation 0.81 0.70 15.71% 0.79 0.67 17.91% 0.94 0.52 80.77% 0.70 0.51 37.25%
PBT 0.20 0.88 -77.27% 1.37 0.80 71.25% 7.57 5.22 45.02% 4.10 9.53 -56.98%
Tax -2.18 0.34 - 0.34 0.31 9.68% 2.18 1.24 75.81% 0.93 0.11 745.45%
PAT 2.38 0.54 340.74% 1.03 0.49 110.20% 5.39 3.99 35.09% 3.17 9.42 -66.35%
PATM 40.48% 9.70% 19.09% 15.26% 40.59% 36.62% 29.90% 49.87%
EPS 0.05 0.01 400.00% 0.02 0.01 100.00% 0.12 0.09 33.33% 0.07 0.22 -68.18%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 35.12 32.59 74.57 58.83 20.49 11.20 11.85 5.66 5.34 5.14 4.83 Net Sales Growth -8.78% -56.30% 26.76% 187.12% 82.95% -5.49% 109.36% 5.99% 3.89% 6.42% Cost Of Goods Sold 8.49 8.12 44.48 45.32 10.35 2.77 3.00 0.99 0.96 1.04 1.75 Gross Profit 26.63 24.48 30.09 13.52 10.14 8.43 8.84 4.67 4.39 4.09 3.07 GP Margin 75.82% 75.12% 40.35% 22.98% 49.49% 75.27% 74.60% 82.51% 82.21% 79.57% 63.56% Total Expenditure 22.97 19.86 55.17 53.47 17.60 9.75 10.31 4.01 3.73 3.67 3.64 Power & Fuel Cost - 0.00 0.00 0.00 0.00 1.78 1.64 0.34 0.29 0.26 0.26 % Of Sales - 0% 0% 0% 0% 15.89% 13.84% 6.01% 5.43% 5.06% 5.38% Employee Cost - 5.47 5.02 4.41 4.57 3.75 4.34 1.91 1.23 1.05 1.13 % Of Sales - 16.78% 6.73% 7.50% 22.30% 33.48% 36.62% 33.75% 23.03% 20.43% 23.40% Manufacturing Exp. - 0.55 0.13 0.12 0.09 0.05 0.03 0.02 0.02 0.02 0.00 % Of Sales - 1.69% 0.17% 0.20% 0.44% 0.45% 0.25% 0.35% 0.37% 0.39% 0% General & Admin Exp. - 5.10 2.95 3.36 2.50 1.35 1.29 0.73 1.22 1.12 0.32 % Of Sales - 15.65% 3.96% 5.71% 12.20% 12.05% 10.89% 12.90% 22.85% 21.79% 6.63% Selling & Distn. Exp. - 0.36 2.12 0.01 0.01 0.04 0.00 0.02 0.02 0.18 0.18 % Of Sales - 1.10% 2.84% 0.02% 0.05% 0.36% 0% 0.35% 0.37% 3.50% 3.73% Miscellaneous Exp. - 0.27 0.47 0.26 0.07 0.01 0.01 0.00 0.00 0.00 0.18 % Of Sales - 0.83% 0.63% 0.44% 0.34% 0.09% 0.08% 0% 0% 0% 0.21% EBITDA 12.16 12.73 19.40 5.36 2.89 1.45 1.54 1.65 1.61 1.47 1.19 EBITDA Margin 34.62% 39.06% 26.02% 9.11% 14.10% 12.95% 13.00% 29.15% 30.15% 28.60% 24.64% Other Income 5.30 4.21 2.82 1.20 0.08 0.36 0.01 0.04 0.11 0.07 0.19 Interest 0.98 0.59 0.28 0.28 0.29 0.03 0.00 0.00 0.04 0.01 0.00 Depreciation 3.24 3.00 2.05 1.84 1.66 1.47 1.48 0.96 0.74 0.47 0.45 PBT 13.24 13.34 19.88 4.44 1.02 0.29 0.07 0.72 0.95 1.06 0.92 Tax 1.27 3.76 1.35 0.04 0.27 -0.09 0.14 0.26 0.42 0.56 0.23 Tax Rate 9.59% 28.19% 6.79% 0.90% 26.47% -100.00% 82.35% 36.11% 44.21% 52.83% 65.71% PAT 11.97 9.58 18.54 4.41 0.75 0.19 0.04 0.46 0.53 0.50 0.12 PAT before Minority Interest 11.97 9.58 18.54 4.41 0.75 0.19 0.04 0.46 0.53 0.50 0.12 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 34.08% 29.40% 24.86% 7.50% 3.66% 1.70% 0.34% 8.13% 9.93% 9.73% 2.48% PAT Growth -17.11% -48.33% 320.41% 488.00% 294.74% 375.00% -91.30% -13.21% 6.00% 316.67% EPS 0.27 0.22 0.42 0.10 0.02 0.00 0.00 0.01 0.01 0.01 0.00

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 62.84 57.64 25.30 16.35 15.60 15.41 15.38 15.01 14.58 14.07 Share Capital 43.79 10.95 3.91 1.57 1.57 1.57 1.57 1.57 1.57 1.57 Total Reserves 19.05 46.69 21.38 14.78 14.03 13.85 13.81 13.44 13.01 12.51 Non-Current Liabilities 6.65 6.04 7.16 6.39 12.97 11.15 9.02 6.43 2.64 2.48 Secured Loans 1.64 1.25 0.90 0.85 0.66 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 1.48 1.41 2.87 2.28 9.11 8.05 6.06 3.58 0.04 0.04 Long Term Provisions 0.13 0.11 0.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 17.28 14.15 42.51 12.38 7.03 6.99 4.00 2.66 1.72 0.73 Trade Payables 9.22 7.22 33.62 8.59 5.33 6.46 3.15 1.93 1.14 0.52 Other Current Liabilities 5.09 6.03 8.78 3.47 0.93 0.00 0.00 0.00 0.00 0.00 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 2.97 0.90 0.10 0.32 0.77 0.52 0.85 0.73 0.58 0.21 Total Liabilities 86.77 77.83 74.97 35.12 35.60 33.55 28.40 24.10 18.94 17.28 Net Block 19.40 19.94 20.23 17.58 17.69 17.38 15.60 14.12 10.09 9.67 Gross Block 43.42 40.97 39.57 35.08 33.53 31.74 28.51 26.06 21.30 20.41 Accumulated Depreciation 24.03 21.02 19.33 17.50 15.83 14.36 12.90 11.94 11.20 10.74 Non Current Assets 21.34 21.60 21.89 19.24 19.55 19.09 17.32 15.83 11.86 11.40 Capital Work in Progress 1.95 1.66 1.66 1.66 1.66 1.66 1.66 1.66 1.72 1.68 Non Current Investment 0.00 0.00 0.00 0.00 0.19 0.05 0.05 0.05 0.04 0.04 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 65.43 56.23 53.07 15.87 16.06 14.45 11.07 8.27 7.08 5.88 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 9.95 2.31 3.16 3.95 1.68 1.39 0.27 0.14 0.32 0.44 Sundry Debtors 8.77 24.51 30.19 7.40 9.75 7.95 5.35 2.93 2.47 0.94 Cash & Bank 12.12 9.98 3.97 0.29 0.50 0.13 0.25 0.06 0.52 1.74 Other Current Assets 34.59 6.19 7.97 0.17 4.12 4.99 5.20 5.14 3.77 2.77 Short Term Loans & Adv. 15.79 13.24 7.78 4.06 3.98 3.77 3.59 3.51 3.35 2.32 Net Current Assets 48.14 42.08 10.57 3.50 9.03 7.47 7.08 5.61 5.36 5.15 Total Assets 86.77 77.83 74.96 35.11 35.61 33.54 28.39 24.10 18.94 17.28

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 7.92 -5.20 3.17 7.99 0.54 1.24 0.26 0.84 -0.29 2.72 PBT 13.34 19.88 4.44 1.02 0.10 0.17 0.72 0.95 1.06 0.35 Adjustment 2.12 1.55 1.60 1.91 1.44 1.58 0.96 0.77 0.47 0.45 Changes in Working Capital -3.78 -26.00 -2.62 5.50 -1.00 -0.51 -1.28 -0.74 -1.43 2.00 Cash after chg. in Working capital 11.68 -4.57 3.42 8.43 0.54 1.24 0.41 0.98 0.10 2.79 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.00 0.00 Tax Paid -3.76 -0.62 -0.25 -0.44 0.00 0.00 -0.15 -0.18 -0.39 -0.08 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1.26 -1.20 -4.43 -1.53 -1.89 -3.11 -2.45 -4.75 -0.93 -0.41 Net Fixed Assets -2.74 -1.40 -4.49 -1.55 -1.79 -3.23 -2.45 -4.70 -0.93 -0.40 Net Investments 0.00 0.00 0.00 0.19 -0.14 0.00 0.00 -0.01 0.00 -0.01 Others 1.48 0.20 0.06 -0.17 0.04 0.12 0.00 -0.04 0.00 0.00 Cash from Financing Activity -4.52 12.41 4.94 -6.68 1.74 1.75 2.38 3.45 0.00 -1.16 Net Cash Inflow / Outflow 2.14 6.01 3.68 -0.21 0.38 -0.12 0.18 -0.46 -1.22 1.15 Opening Cash & Equivalents 9.98 3.97 0.29 0.50 0.13 0.25 0.06 0.52 1.74 0.59 Closing Cash & Equivalent 12.12 9.98 3.97 0.29 0.50 0.13 0.25 0.06 0.52 1.74

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 1.44 1.32 16.16 21.74 99.63 98.43 98.20 95.86 93.10 89.89 ROA 11.63% 24.26% 8.01% 2.12% 0.54% 0.11% 1.76% 2.44% 2.78% 0.67% ROE 15.90% 44.70% 21.16% 4.70% 1.21% 0.23% 3.04% 3.55% 3.51% 0.85% ROCE 21.80% 44.24% 18.85% 5.79% 0.54% 0.77% 3.62% 5.94% 7.41% 2.40% Fixed Asset Turnover 0.77 1.85 1.58 0.60 0.34 0.46 0.24 0.24 0.25 0.24 Receivable days 186.38 133.86 116.60 152.77 288.50 176.69 228.42 170.95 120.92 54.99 Inventory Days 68.70 13.39 22.06 50.20 50.01 22.02 11.47 14.59 26.67 67.13 Payable days 369.82 167.55 170.00 245.53 761.94 159.63 199.65 154.07 83.12 46.94 Cash Conversion Cycle -114.74 -20.30 -31.34 -42.56 -423.43 39.09 40.24 31.47 64.47 75.18 Total Debt/Equity 0.07 0.05 0.20 0.21 0.63 0.52 0.39 0.24 0.00 0.00 Interest Cover 23.42 70.77 16.82 4.55 3.94 84.02 1166.32 24.45 182.99 256.48

Top Investors:

renuka yogesh parikh

yogesh biharilal parikh

Annual Reports:

News Update:

Shukra Pharmaceuticals partners with Wockhardt
11th Sep 2025, 15:20 PM

The arrangement will strengthen the company’s presence in institutional and government healthcare networks across India
Read More
Shukra Pharmaceuticals bags contract from HSCC (India)
29th Aug 2025, 09:30 AM

The company has received a LoA on dated August 28, 2025 for the supply of Medicines and Diagnostic Kits to Afghanistan
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback